A label of excellence for multidisciplinary and integrated research
The designation by the French National Cancer Institute (INCa) of Integrated Cancer Research Sites (SIRIC) is a policy of the French government who supports, through the Plan Cancer, the national effort to reduce the mortality and morbidity from cancer.
In order to continue the momentum initiated, the French National Cancer Institute launched in 2017 in partnership with Ministry of Health (DGOS) and Inserm a new call for application for SIRIC designation. The new campaign was opened to previously designated sites as well as to new projects. Following an international scientific evaluation, 8 projects out of the 16 applications submitted were selected for SIRIC-designation for a 5-year period (2018-2022).